Cite
HARVARD Citation
Mayr, J. et al. (2017). An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo. Chemical science. 8 (3), pp. 2241-2250. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mayr, J. et al. (2017). An albumin-based tumor-targeted oxaliplatin prodrug with distinctly improved anticancer activity in vivo. Chemical science. 8 (3), pp. 2241-2250. [Online].